NCT04466891 A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers Status COMPLETED Phase PHASE2
NCT04447846 Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome Status COMPLETED Phase PHASE2
NCT04425655 Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia. Status TERMINATED Phase PHASE2
NCT04421456 Trial to Investigate the Safety and Efficacy of GWP42003-P Versus Placebo as Adjunctive Therapy in Participants With Schizophrenia Experiencing Inadequate Response to Ongoing Antipsychotic Treatment Status TERMINATED Phase PHASE2
NCT04389840 Dociparstat for the Treatment of Severe COVID-19 in Adults at High Risk of Respiratory Failure Status TERMINATED Phase PHASE2/PHASE3
NCT04291937 A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA Status APPROVED_FOR_MARKETING Phase N/A
NCT04285788 Incidence and Outcomes Associated With the Management of Adenovirus Infections in Allogenic Hematopoietic Cell Transplant Recipients Status COMPLETED Phase N/A
NCT04269213 CPX-351 for the Treatment of Secondary Acute Myeloid Leukemia in Patients Younger Than 60 Years Old Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04268966 An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola Status WITHDRAWN Phase PHASE2
NCT04252586 A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome Status TERMINATED Phase PHASE3
NCT04231851 CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04224272 A Study of ZW25 (Zanidatamab) With Palbociclib Plus Fulvestrant in Patients With HER2+/HR+ Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT04217278 A Trial of Treatments to Assess the Effects on Outcome of Adults With AML and MDS Undergoing Allogeneic SCT Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT04203498 Safety and Effectiveness of Nabiximols Oromucosal Spray as Add-on Therapy in Participants With Spasticity Due to Multiple Sclerosis Status TERMINATED Phase PHASE3
NCT04195945 CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients Status COMPLETED Phase PHASE2
NCT04176042 Community-Level Daytime Sleepiness: Social-Environmental Determinants, Consequences, and Impact of Sleep Apnea Status COMPLETED Phase NA
NCT04145531 An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) Status COMPLETED Phase PHASE2/PHASE3
NCT04133480 Investigation of Cognitive Outcomes With Cannabidiol Oral Solution Status WITHDRAWN Phase PHASE4
NCT04075747 A Phase 1b Master Trial to Investigate CPX-351 in Subjects With Previously Untreated Acute Myeloid Leukemia Status COMPLETED Phase PHASE1